» Articles » PMID: 15121480

Polymorphisms in the 13q33.2 Gene G72/G30 Are Associated with Childhood-onset Schizophrenia and Psychosis Not Otherwise Specified

Overview
Journal Biol Psychiatry
Publisher Elsevier
Specialty Psychiatry
Date 2004 May 4
PMID 15121480
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Childhood-onset schizophrenia (COS), defined as onset of psychotic symptoms by age 12 years, is a rare and severe form of the disorder that seems to be clinically and neurobiologically continuous with the adult disorder.

Methods: We studied a rare cohort consisting of 98 probands; 71 of these probands received a DSM-defined diagnosis of schizophrenia, and the remaining 27 were diagnosed as psychosis not otherwise specified (NOS) (upon 2-6 year follow-up, 13 have subsequently developed bipolar disorder). Two overlapping genes, G72 and G30 on 13q33.2, were identified through linkage-disequilibrium-based positional cloning. Single nucleotide polymorphisms (SNPs) at the G72/G30 locus were independently associated with both bipolar illness and schizophrenia. We analyzed SNPs at this locus with a family-based transmission disequilibrium test (TDT) and haplotype analyses for the discrete trait, as well as quantitative TDT for intermediate phenotypes, using the 88 probands (including COS and psychosis-NOS) with parental participation.

Results: We observed significant pairwise and haplotype associations between SNPs at the G72/G30 locus and psychotic illness. Furthermore, these markers showed associations with scores on a premorbid phenotype measured by the Autism Screening Questionnaire, and with age of onset.

Conclusions: These findings, although limited by potential referral bias, confirm and strengthen previous reports that G72/G30 is a susceptibility locus both for schizophrenia and bipolar disorder.

Citing Articles

Variations of blood D-serine and D-aspartate homeostasis track psychosis stages.

Rampino A, Garofalo M, Nuzzo T, Favia M, Saltarelli S, Masellis R Schizophrenia (Heidelb). 2024; 10(1):115.

PMID: 39702391 PMC: 11659589. DOI: 10.1038/s41537-024-00537-2.


Rational and Translational Implications of D-Amino Acids for Treatment-Resistant Schizophrenia: From Neurobiology to the Clinics.

de Bartolomeis A, Vellucci L, Austin M, De Simone G, Barone A Biomolecules. 2022; 12(7).

PMID: 35883465 PMC: 9312470. DOI: 10.3390/biom12070909.


Biochemical Properties and Physiological Functions of pLG72: Twenty Years of Investigations.

Murtas G, Pollegioni L, Molla G, Sacchi S Biomolecules. 2022; 12(6).

PMID: 35740983 PMC: 9220908. DOI: 10.3390/biom12060858.


d-Amino Acids and pLG72 in Alzheimer's Disease and Schizophrenia.

Cheng Y, Lin C, Lane H Int J Mol Sci. 2021; 22(20).

PMID: 34681579 PMC: 8535920. DOI: 10.3390/ijms222010917.


Childhood-Onset Schizophrenia: A Systematic Overview of Its Genetic Heterogeneity From Classical Studies to the Genomic Era.

Fernandez A, Drozd M, Thummler S, Dor E, Capovilla M, Askenazy F Front Genet. 2020; 10:1137.

PMID: 31921276 PMC: 6930680. DOI: 10.3389/fgene.2019.01137.